Foster Dykema Cabot & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $119K | Buy |
2,045
+166
| +9% | +$10.2K | 0.01% | 125 |
|
|
2023
Q2 | $120K | Hold |
1,879
| – | – | 0.01% | 130 |
|
|
2023
Q1 | $130K | Buy |
+1,879
| New | +$133K | 0.02% | 107 |
|
|
2022
Q4 | – | Sell |
-8,580
| Closed | -$610K | – | 81 |
|
|
2022
Q3 | $610K | Hold |
8,580
| – | – | 0.08% | 48 |
|
|
2022
Q2 | $661K | Hold |
8,580
| – | – | 0.08% | 46 |
|
|
2022
Q1 | $627K | Sell |
8,580
-2,277
| -21% | -$153K | 0.08% | 54 |
|
|
2021
Q4 | $677K | Hold |
10,857
| – | – | 0.08% | 56 |
|
|
2021
Q3 | $642K | Buy |
10,857
+500
| +5% | +$32.9K | 0.08% | 58 |
|
|
2021
Q2 | $692K | Hold |
10,357
| – | – | 0.09% | 54 |
|
|
2021
Q1 | $654K | Hold |
10,357
| – | – | 0.09% | 54 |
|
|
2020
Q4 | $642K | Hold |
10,357
| – | – | 0.09% | 57 |
|
|
2020
Q3 | $624K | Hold |
10,357
| – | – | 0.1% | 57 |
|
|
2020
Q2 | $609K | Buy |
10,357
+67
| +0.7% | +$4.01K | 0.11% | 52 |
|
|
2020
Q1 | $574K | Sell |
10,290
-305
| -3% | -$18.6K | 0.11% | 48 |
|
|
2019
Q4 | $680K | Hold |
10,595
| – | – | 0.1% | 51 |
|
|
2019
Q3 | $537K | Hold |
10,595
| – | – | 0.08% | 70 |
|
|
2019
Q2 | $480K | Hold |
10,595
| – | – | 0.07% | 75 |
|
|
2019
Q1 | $505K | Hold |
10,595
| – | – | 0.08% | 67 |
|
|
2018
Q4 | $551K | Hold |
10,595
| – | – | 0.1% | 58 |
|
|
2018
Q3 | $658K | Hold |
10,595
| – | – | 0.11% | 56 |
|
|
2018
Q2 | $624K | Hold |
10,595
| – | – | 0.1% | 59 |
|
|
2018
Q1 | $670K | Hold |
10,595
| – | – | 0.11% | 63 |
|
|
2017
Q4 | $649K | Hold |
10,595
| – | – | 0.11% | 62 |
|
|
2017
Q3 | $675K | Hold |
10,595
| – | – | 0.12% | 58 |
|
|
2017
Q2 | $590K | Sell |
10,595
-75
| -0.7% | -$4.08K | 0.11% | 66 |
|
|
2017
Q1 | $580K | Hold |
10,670
| – | – | 0.11% | 63 |
|
|
2016
Q4 | $624K | Hold |
10,670
| – | – | 0.12% | 63 |
|
|
2016
Q3 | $575K | Hold |
10,670
| – | – | 0.13% | 67 |
|
|
2016
Q2 | $785K | Sell |
10,670
-230
| -2% | -$16.3K | 0.18% | 50 |
|
|
2016
Q1 | $696K | Hold |
10,900
| – | – | 0.17% | 49 |
|
|
2015
Q4 | $750K | Sell |
10,900
-40
| -0.4% | -$2.64K | 0.19% | 45 |
|
|
2015
Q3 | $648K | Hold |
10,940
| – | – | 0.17% | 48 |
|
|
2015
Q2 | $728K | Sell |
10,940
-300
| -3% | -$19.8K | 0.19% | 46 |
|
|
2015
Q1 | $725K | Hold |
11,240
| – | – | 0.18% | 47 |
|
|
2014
Q4 | $663K | Hold |
11,240
| – | – | 0.16% | 49 |
|
|
2014
Q3 | $575K | Hold |
11,240
| – | – | 0.14% | 48 |
|
|
2014
Q2 | $545K | Hold |
11,240
| – | – | 0.13% | 55 |
|
|
2014
Q1 | $584K | Hold |
11,240
| – | – | 0.15% | 51 |
|
|
2013
Q4 | $597K | Hold |
11,240
| – | – | 0.16% | 52 |
|
|
2013
Q3 | $520K | Hold |
11,240
| – | – | 0.15% | 54 |
|
|
2013
Q2 | $502K | Buy |
+11,240
| New | +$488K | 0.15% | 55 |
|
Other funds holding BMY
Foster Dykema Cabot & Co's BMY Position: Q3 2023 in Review
Foster Dykema Cabot & Co increased its Bristol-Myers Squibb (BMY) stake by 8.8% in Q3 2023, buying an estimated $10.2K and bringing the position to 2,045 shares worth $119K. The position accounts for 0.01% of the portfolio, ranked #125.
Foster Dykema Cabot & Co first reported a position in BMY in Q2 2013 and has held it in 41 quarters since. The position peaked at $785K in Q2 2016. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- Foster Dykema Cabot & Co held 2,045 shares of Bristol-Myers Squibb worth $119K as of Q3 2023.
- Foster Dykema Cabot & Co bought 166 Bristol-Myers Squibb shares in Q3 2023, an estimated $10.2K.
- Bristol-Myers Squibb made up 0.01% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #125 holding.
- Foster Dykema Cabot & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 41 quarters since.
- Foster Dykema Cabot & Co's Bristol-Myers Squibb position peaked at $785K in Q2 2016.
- 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.